ArticleKidney medicine2026

Safety and Effectiveness of Daratumumab in Recurrent and De Novo Focal Segmental Glomerulosclerosis After Kidney Transplant.

Rohan V Mehta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.